(Q50786602)

19 March 2018

title

Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine. (English)

1 reference

19 March 2018

1 reference

Ramaiah KD

1

1 reference

19 March 2018

Vanamail P

series ordinal

2

1 reference

19 March 2018

Das PK

series ordinal

3

1 reference

19 March 2018

publication date

4 August 2006

1 reference

19 March 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

19 March 2018

volume

101

1 reference

19 March 2018

issue

3

1 reference

19 March 2018

page(s)

250-255

1 reference

19 March 2018

Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Mass treatment to eliminate filariasis in Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a ho

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Estimation of permissible levels of transmission of bancroftian filariasis based on some entomological and parasitological results of a 5-year vector control programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

The prevalences ofWuchereria bancroftiantigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Parasite antigenemia without microfilaremia in bancroftian filariasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

Lymphatic filariasis: an infection of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.007

10.1016/J.TRSTMH.2006.05.007

7 January 2021

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018